Patient preferences for pancreatic cancer treatment (PERSEUS): a multicenter discrete choice experiment
Pancreatic cancer patients, both with early-stage and late-stage disease, choose for anti-cancer treatment over best supportive care and value life expectancy as the most important treatment attribute, although significant differences exist between patients.
Authors
- G. Frederix
- Ernst van Alphen (ORCID: https://orcid.org/0000-0002-3980-5354)
- Bert A. Bonsing (ORCID: https://orcid.org/0000-0003-4513-5737)
- Simone Augustinus (ORCID: https://orcid.org/0000-0002-0625-4349)
- Pythia T. Nieuwkerk (ORCID: https://orcid.org/0000-0002-2616-1414)
- Pauline A J Vissers
- Ignace H J T de Hingh
- Marjolein Y V Homs
- I. Quintus. Molenaar
- Maarten F. Bijlsma
- Ian P. Smith
- Judith de Vos – Geelen
- Hanneke W. M. van Laarhoven
- Marc G. Besselink
- Brigitte C. M. Haberkorn
- Marjolein F. Lansbergen
- Johanna W. Wilmink
- for the Dutch Pancreatic Cancer Group
- Ilse J. M. Fransen
Institutions
- Radboud University Nijmegen (NL)
- Utrecht University (NL)
- Leiden University Medical Center (NL)
- Maastricht University Medical Centre (NL)
- Catharina Ziekenhuis (NL)
- Radboud University Medical Center (NL)
- University Medical Center Utrecht (NL)
- Maastricht University (NL)
- Amsterdam Neuroscience (NL)
- Maasstad Ziekenhuis (NL)
- Netherlands Comprehensive Cancer Organisation (NL)
- Erasmus MC Cancer Institute (NL)
- Amsterdam University Medical Centers (NL)
- Cancer Center Amsterdam (NL)
- Amsterdam University of Applied Sciences (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- Health and Quality of Life Outcomes
- Published
- 2025-12-24
- DOI
- https://doi.org/10.1186/s12955-025-02440-5
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00